Ayurveda and Homoeopathy graduates found practicing allopathy in Sangareddy
Led by TGMC president Mahesh Kumar, five inspection teams combed through around 25 clinics and hospitals located in Old Bus Stand, Malkapur, Isnapur, Sadashivpet, Konkole, Daulatabad, Narsapur, and Zaheerabad. During the inspections, officials uncovered that several individuals with BAMS, BHMS and D.Pharm qualifications were not only practicing allopathic medicine without authorisation but were also administering medications typically reserved for use by licensed allopathic doctors. Some facilities were found operating without any formal registration or licenses, TGMC said.
Such actions violate Sections 34 and 54 of the National Medical Commission (NMC) Act, and the TGMC has announced strong measures to address these violations. 'A detailed report will be submitted to the District Collector and the District Medical and Health Officer (DMHO). Clinics and hospitals found without proper registration will face legal action, including recommendations for closure. The Medical Council will file FIRs against those violating the NMC Act. All further proceedings will be pursued through legal means,' said Dr. Mahesh Kumar.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
13 hours ago
- The Hindu
Chemists' body seeks action against startups for unauthorised tampering, repacking of medicine strips
The Bangalore District Chemists and Druggists Association (BDCDA) has written to the Drug Controller General of India (DCGI) demanding immediate regulatory action against two health-tech startups, who are engaged in alleged unauthorised tampering and repacking of statutory medicine strips. In a letter dated July 30, the BDCDA claimed that such actions are in contravention of the Drugs and Cosmetics Act, 1940, and Rules, 1945. 'Such tampering and repacking of medicine strips threaten patient safety, undermine ethical pharmacy practices, and erode confidence in the regulatory framework,' the letter stated. Pointing out that the All India Organisation of Chemists and Druggists (AIOCD) has already taken up the issue of one such startup at the national level, the BDCDA has said that tampering with statutory packaging, unlawfully repacking medicines, and disregarding essential stability and labelling norms by the two health-tech companies put public health at risk. Specific violations Highlighting specific violations under the Drugs and Cosmetics Act, 1940, and Rules, 1945, BDCDA president B. Thirunavukkarasu told The Hindu that such actions amounted to willful destruction or removal of statutory labels, batch numbers, expiry dates, MRP, and mandatory warnings - effectively stripping medicines of their legally required safeguards, and thereby endangering consumer safety under Rule 96 and Rule 97 of the Act. Compromising the stability, potency, and therapeutic efficacy of medicines by exposing them to contamination and temperature variations through improper handling, storage, and repackaging practices amounted to violation of Schedule P1, he said. GMP and GSP violations 'Carrying out repacking in unlicensed, non-compliant, and uncontrolled environments grossly violates the principles of Good Manufacturing Practices (GMP) and Good Storage Practices (GSP) mandated under the law. Besides, misrepresenting these unlawful and unethical acts as 'tech-enabled innovations', or 'patient-friendly services' mislead consumers and erode the credibility of India's ethical pharmacy community,' he said. Apart from all these violations, the sale of medicines through online platforms continues unchecked, lacking any legal authorisation or structured regulatory mechanism, Mr. Thirunavukkarasu added.
The Hindu
15 hours ago
- The Hindu
Submit report on all abortion cases in Chittoor district, Collector directs officials
District Collector Sumit Kumar on Friday instructed officials of the Medical and Health Department to immediately verify all abortion cases reported in both government and private hospitals and submit a detailed report to ascertain the causes. He was addressing a meeting on the implementation of the Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act. Emphasising the importance of promoting safe and normal deliveries in government hospitals and primary health centres (PHCs), Mr. Sumit Kumar said that each PHC should aim to conduct at least 50 normal deliveries per month. The Collector warned of disciplinary action against officials found negligent in their duties, especially those ignoring the activities of unqualified practitioners involved in illegal procedures. 'Centres violating medical norms must be shut down immediately,' he said. He also directed ASHA workers, Auxiliary Nurse Midwives (ANMs), and Anganwadi staff to closely monitor abortion trends and report any suspicious activity confidentially. Stressing the need for monthly inspections, public awareness campaigns, and coordinated departmental efforts, Mr. Sumit Kumar said that strong measures were necessary to curb sex determination practices. He warned that criminal proceedings would be initiated against violators and scanning centres found conducting illegal gender determination tests.
Indian Express
20 hours ago
- Indian Express
Despite increase in MBBS seats, 2,849 remained vacant in 2024: Govt data
Despite a significant 39 per cent increase in MBBS seats over the past few years, a considerable number of undergraduate medical seats remain vacant across India, data from the National Medical Commission (NMC) reveals. The data was presented in the Lok Sabha on August 1 by Anupriya Patel, Minister of State in the Ministry of Health and Family Welfare. The unstarred question was asked by a member of the Telugu Desam Party, Putta Mahesh Kumar. The number of MBBS seats rose from 83,275 in 2020–21 to 1,15,900 by 2024–25; however, the number of vacant UG seats (excluding AIIMS and JIPMER) peaked at 4,146 in 2022–23, before witnessing a gradual decline to 2,849 in 2024–25. The government attributes this expansion to the establishment of new medical colleges and improvements in infrastructure and faculty availability. To ensure quality, the Minimum Standard Requirement Regulations, 2023, have been introduced by NMC. These regulations outline essential standards regarding infrastructure, clinical materials, faculty, and necessary facilities required for establishing and maintaining medical colleges. The government data also showed the number of medical seats in India across the country in 2020-21 and 2024-25. UP, Tamil Nadu, Karnataka, Maharashtra and Gujarat top the list. In the Lok Sabha, the government has also mentioned the steps they have taken to increase the medical seats in colleges and institutes in the country. As mentioned in the data, under the centrally sponsored scheme for establishing new medical colleges, district and referral hospitals are being upgraded, particularly in underserved and aspirational districts. Out of the 157 approved medical colleges under this scheme, 131 are already functional. In addition, efforts are underway to enhance the capacity of existing state and central government medical colleges through a separate centrally sponsored scheme. This aims at strengthening infrastructure and increasing the number of MBBS and postgraduate (PG) seats. Furthermore, under the upgradation of the government medical colleges by the construction of Super Speciality Blocks as part of the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY), 75 projects have been approved, of which 71 have been completed. Under the central sector scheme for establishing new All India Institutes of Medical Sciences (AIIMS), 22 AIIMS have been approved, and undergraduate courses have already commenced in 19 of them.
